Concepedia

Author

G. Frank Liu

Merck & Co., Inc., Rahway, NJ, USA (United States)ORCID

Also Known As

G. Frank Liu, GUANGHAN LIU, Guanghan (Frank) Liu, Guanghan F. Liu, Guanghan Frank Liu, Guanghan Liu, Guankui Liu, Liu, Guanghan Frank

62

Publications

2.4K

Citations

17

H-Index

38

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)United States Military AcademyUniversity of North Carolina at Chapel HillSanofi (United States)George Mason University
GF

About

G. Frank Liu is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in statistics, medicine, and biostatistics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

7

7

1.6K

2

Health Sciences

3

3

74

3

Public Health

3

3

114

4

Engineering

2

2

35

5

Social Sciences

2

2

1.4K

G. Frank Liu

×

23

Publications

2.2K

Citations

17

H-Index

YearCitations

Distinct Mechanism for Antidepressant Activity by Blockade of Central Substance P Receptors

Mark S. Kramer, Neal R. Cutler, John P. Feighner,

Science

1998

1.1K

Lack of Efficacy of the Substance P (Neurokinin1 Receptor) Antagonist Aprepitant in the Treatment of Major Depressive Disorder

Martin B. Keller, Stuart Montgomery, William A. Ball,

Biological Psychiatry

2005

287

Should baseline be a covariate or dependent variable in analyses of change from baseline in clinical trials?

G. Frank Liu, Kaifeng Lu, Robin Mogg,

Statistics in Medicine

2009

236

IMPROVED DESIGNS FOR DOSE ESCALATION STUDIES USING PHARMACOKINETIC MEASUREMENTS

Steven Piantadosi, G. Frank Liu

Statistics in Medicine

1996

117

COMPARISON OF ALTERNATIVE STRATEGIES FOR ANALYSIS OF LONGITUDINAL TRIALS WITH DROPOUTS

G. Frank Liu, A. Lawrence Gould

Journal of Biopharmaceutical Statistics

2002

102

Confidence intervals for an exposure adjusted incidence rate difference with applications to clinical trials

G. Frank Liu, Junyuan Wang, Kenneth Liu,

Statistics in Medicine

2005

69

Evaluating the adaptive performance of flexible sample size designs with treatment difference in an interval

G. Frank Liu, Guangrui Zhu, Lu Cui

Statistics in Medicine

2007

34

A Phase III Randomized, Double-blind, Clinical Trial of an Investigational Hexavalent Vaccine Given at Two, Three, Four and Twelve Months

Timo Vesikari, Thomas Becker, André Vertruyen,

The Pediatric Infectious Disease Journal

2016

34

Immunogenicity, Safety, and Tolerability of a Hexavalent Vaccine in Infants

Gary S. Marshall, Gregory L. Adams, Michael Leonardi,

PEDIATRICS

2015

31

Bayesian probability of success for clinical trials using historical data

Joseph G. Ibrahim, Ming‐Hui Chen, Mani Lakshminarayanan,

Statistics in Medicine

2014

27

Page 1